Protagonist Therapeutics (PTGX) shares outstanding

Shares outstanding · fiscal 2025
63.57M

Protagonist Therapeutics (PTGX) had 63.57M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.3% lower than the 65.08M of fiscal 2024. Figures as of 18 Nov 2026, 12:24 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
63.57M
Change on fiscal 2024
−2.3%
Growth, 5 years
+13.1% a year
Highest on record
65.08Mfiscal 2024
Lowest on record
34.40Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Protagonist Therapeutics shares outstanding, in more detail

The market data feed counts 65.27M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 13.1% a year. Across the 6 fiscal years on record (2020–2025), the highest was 65.08M in fiscal 2024 and the lowest 34.40M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Protagonist Therapeutics shares outstanding, year by year

Protagonist Therapeutics (PTGX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202563.57M 2.3% down
202465.08M 14.6% up
202356.76M 15.7% up
202249.04M 5.9% up
202146.32M 34.7% up
202034.40M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Protagonist Therapeutics and comparable companies
CompanyShares outstandingFiscal year
Twist Bioscience TWST62.62M2026
Protagonist Therapeutics PTGX63.57M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTGX

Protagonist Therapeutics, figure by figure

Protagonist Therapeutics (PTGX) overview: price, valuation and scorecardAll health care companies by market value

Protagonist Therapeutics shares outstanding: questions and answers

How many shares does Protagonist Therapeutics have?

Protagonist Therapeutics (PTGX) had 63.57M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.3% lower than the 65.08M of fiscal 2024. The market data feed counts 65.27M shares outstanding today.

What is the growth rate of Protagonist Therapeutics's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 13.1% a year.

What are the highest and lowest diluted share count figures on record for Protagonist Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was 65.08M in fiscal 2024 and the lowest 34.40M in fiscal 2020.

How is Protagonist Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Protagonist Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Protagonist Therapeutics (PTGX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/PTGX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.